197 related articles for article (PubMed ID: 32840470)
21. No Prognostic Impact of Staging Brain MRI in Patients with Stage IA Non-Small Cell Lung Cancer.
Nam JG; Hong H; Choi SH; Park CM; Goo JM; Kim YT; Kim H
Radiology; 2022 Jun; 303(3):632-643. PubMed ID: 35258373
[TBL] [Abstract][Full Text] [Related]
22. Prospective comparison of
Kirchner J; Sawicki LM; Nensa F; Schaarschmidt BM; Reis H; Ingenwerth M; Bogner S; Aigner C; Buchbender C; Umutlu L; Antoch G; Herrmann K; Heusch P
Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):437-445. PubMed ID: 30074073
[TBL] [Abstract][Full Text] [Related]
23. 7-year follow-up after stereotactic ablative radiotherapy for patients with stage I non-small cell lung cancer: Results of a phase 2 clinical trial.
Sun B; Brooks ED; Komaki RU; Liao Z; Jeter MD; McAleer MF; Allen PK; Balter PA; Welsh JD; O'Reilly MS; Gomez D; Hahn SM; Roth JA; Mehran RJ; Heymach JV; Chang JY
Cancer; 2017 Aug; 123(16):3031-3039. PubMed ID: 28346656
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic Yield and False-Referral Rate of Staging Chest CT in Patients with Colon Cancer.
Lee KH; Park JH; Kim YH; Lee KW; Kim JW; Oh HK; Jeon JJ; Yoon H; Kim J; Lee KH
Radiology; 2018 Nov; 289(2):535-545. PubMed ID: 30084734
[TBL] [Abstract][Full Text] [Related]
25. Preoperative brain MRI for clinical stage IA lung cancer: is routine scanning rational?
Zhuge L; Huang Y; Wang S; Xie J; Huang B; Zheng D; Zheng S; Zhao Y; Mao H; Wilson DO; Luketich JD; Xiang J; Chen H; Zhang J
J Cancer Res Clin Oncol; 2019 Feb; 145(2):503-509. PubMed ID: 30536037
[TBL] [Abstract][Full Text] [Related]
26. Early stage non-small cell lung cancer patients need brain imaging regardless of symptoms.
Ando T; Kage H; Saito M; Amano Y; Goto Y; Nakajima J; Nagase T
Int J Clin Oncol; 2018 Aug; 23(4):641-646. PubMed ID: 29484515
[TBL] [Abstract][Full Text] [Related]
27. Routine preoperative brain CT in resectable non-small cell lung cancer - Ten years experience from a tertiary UK thoracic center.
Matys T; Drury R; David S; Rassl DM; Qian W; Rintoul RC; Screaton NJ
Lung Cancer; 2018 Aug; 122():195-199. PubMed ID: 30032831
[TBL] [Abstract][Full Text] [Related]
28. CT Features of Epidermal Growth Factor Receptor-Mutated Adenocarcinoma of the Lung: Comparison with Nonmutated Adenocarcinoma.
Hasegawa M; Sakai F; Ishikawa R; Kimura F; Ishida H; Kobayashi K
J Thorac Oncol; 2016 Jun; 11(6):819-26. PubMed ID: 26917231
[TBL] [Abstract][Full Text] [Related]
29. Predictive value of primary fluorine-18 fluorodeoxyglucose standard uptake value for a better choice of systematic nodal dissection or sampling in clinical stage ia non--small-cell lung cancer.
Li X; Zhang H; Xing L; Xu X; Xie P; Ma H; Zhang L; Chen M; Sun X; Xu W; Chen L; Yu J
Clin Lung Cancer; 2013 Sep; 14(5):568-73. PubMed ID: 23835164
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic value of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for the detection of metastases in non-small-cell lung cancer patients.
Wu Y; Li P; Zhang H; Shi Y; Wu H; Zhang J; Qian Y; Li C; Yang J
Int J Cancer; 2013 Jan; 132(2):E37-47. PubMed ID: 22890912
[TBL] [Abstract][Full Text] [Related]
31. Pure ground glass nodular adenocarcinomas: Are preoperative positron emission tomography/computed tomography and brain magnetic resonance imaging useful or necessary?
Cho H; Lee HY; Kim J; Kim HK; Choi JY; Um SW; Lee KS
J Thorac Cardiovasc Surg; 2015 Sep; 150(3):514-20. PubMed ID: 26189165
[TBL] [Abstract][Full Text] [Related]
32. Trends in stage distribution for patients with non-small cell lung cancer: a National Cancer Database survey.
Morgensztern D; Ng SH; Gao F; Govindan R
J Thorac Oncol; 2010 Jan; 5(1):29-33. PubMed ID: 19952801
[TBL] [Abstract][Full Text] [Related]
33. [Comparison of computed tomography and magnetic resonance imaging to diagnose brain metastasis in non-small cell lung cancer].
Ozgül MA; Uysal MA; Kadakal F; Altoparlak B; Cinemre H; Yilmaz V
Tuberk Toraks; 2006; 54(3):229-34. PubMed ID: 17001539
[TBL] [Abstract][Full Text] [Related]
34. Performance Comparison Between
Kishida Y; Seki S; Yoshikawa T; Itoh T; Maniwa Y; Nishimura Y; Ohno Y
AJR Am J Roentgenol; 2018 Jul; 211(1):185-192. PubMed ID: 29667886
[TBL] [Abstract][Full Text] [Related]
35. Tumor cavitation in stage I non-small cell lung cancer: epidermal growth factor receptor expression and prediction of poor outcome.
Onn A; Choe DH; Herbst RS; Correa AM; Munden RF; Truong MT; Vaporciyan AA; Isobe T; Gilcrease MZ; Marom EM
Radiology; 2005 Oct; 237(1):342-7. PubMed ID: 16183941
[TBL] [Abstract][Full Text] [Related]
36. Single organ metastatic disease and local disease status, prognostic factors for overall survival in stage IV non-small cell lung cancer: Results from a population-based study.
Hendriks LE; Derks JL; Postmus PE; Damhuis RA; Houben RM; Troost EG; Hochstenbag MM; Smit EF; Dingemans AM
Eur J Cancer; 2015 Nov; 51(17):2534-44. PubMed ID: 26323530
[TBL] [Abstract][Full Text] [Related]
37. Anaplastic lymphoma kinase gene rearrangements in cytological samples of non-small cell lung cancer: comparison with histological assessment.
Proietti A; Alì G; Pelliccioni S; Lupi C; Sensi E; Boldrini L; Servadio A; Chella A; Ribechini A; Cappuzzo F; Miccoli M; Fontanini G
Cancer Cytopathol; 2014 Jun; 122(6):445-53. PubMed ID: 24648382
[TBL] [Abstract][Full Text] [Related]
38. Clinical and computed tomography characteristics of non-small cell lung cancer with ALK gene rearrangement: Comparison with EGFR mutation and ALK/EGFR-negative lung cancer.
Mori M; Hayashi H; Fukuda M; Honda S; Kitazaki T; Shigematsu K; Matsuyama N; Otsubo M; Nagayasu T; Hashisako M; Tabata K; Uetani M; Ashizawa K
Thorac Cancer; 2019 Apr; 10(4):872-879. PubMed ID: 30811109
[TBL] [Abstract][Full Text] [Related]
39. Predictive risk factors for mediastinal lymph node metastasis in clinical stage IA non-small-cell lung cancer patients.
Koike T; Koike T; Yamato Y; Yoshiya K; Toyabe S
J Thorac Oncol; 2012 Aug; 7(8):1246-51. PubMed ID: 22659962
[TBL] [Abstract][Full Text] [Related]
40. Endobronchial ultrasound-guided transbronchial needle aspiration for lymph node staging in patients with non-small cell lung cancer in non-operable patients pursuing radiotherapy as a primary treatment.
Nakajima T; Yasufuku K; Nakajima M; Baba M; Yoshikawa K; Kamada T; Hiroshima K; Nakatani Y; Fujisawa T; Yoshino I
J Thorac Oncol; 2010 May; 5(5):606-11. PubMed ID: 20354458
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
